Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by goregilon Feb 19, 2018 3:08am

131 Views

Post# 27582299

Re inquiring minds want to know

Thanks gojotv we got a unexpected gift with our low dose pdc with the killing of all cancer cells .My point is will we see any benefits of a higher dose.I know we are gathering more usefull information but our aim is to kill cancer with a with a immune response so cancer will not return .will a higher dose accomplish this? Only time will tell

Bullboard Posts

FE Battery Metals begins 2024 winter drill program